Antimicrobial resistance (amr): India's battle against the silent pandemic

Understanding Health and Disease

The World Health Organization (WHO) defines health not merely as the absence of disease, but as “a state of complete physical, mental and social well-being.” This holistic view is crucial for public policy, as a healthy populace drives productivity, economic prosperity, and social stability. Diseases are broadly classified into communicable and non-communicable types.

Communicable diseases are illnesses that spread from one person to another, or from an animal to a person. Their transmission can occur through various pathways, making them a significant public health concern.

Fun Fact: The 1918 Flu Pandemic, a communicable disease, infected about 500 million people—one-third of the world’s population at the time—and caused an estimated 50 million deaths worldwide.

Modes of Disease Transmission

Understanding how diseases spread is the first step in preventing them. The primary modes of transmission are summarized below:

The Rising Threat: Antimicrobial Resistance (AMR)

One of the most critical challenges in modern medicine is Antimicrobial Resistance (AMR). This occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness, and death.

The primary drivers behind the emergence of AMR are multifaceted and can be remembered with a mnemonic.

Key Drivers of AMR

1. Misuse and overuse of antimicrobials in human medicine.
2. Agricultural use of antibiotics for growth promotion in livestock.
3. Sanitation and hygiene deficits in communities and healthcare facilities.
4. Therapeutic non-compliance (patients not completing their full treatment course).
5. Environmental contamination from pharmaceutical manufacturing and waste.
6. Regulatory gaps in drug quality and sales.

Mnemonic for AMR Drivers: MASTER

Startling Statistic: A landmark 2022 global study published in The Lancet estimated that AMR was directly responsible for 1.27 million deaths in 2019, and associated with nearly 5 million deaths, making it a leading cause of death globally, more than HIV/AIDS or malaria. Projections suggest this could rise to 10 million deaths annually by 2050 if unchecked.

India’s Strategic Response to AMR: A Dynamic Update

India, being one of the largest consumers of antibiotics globally, is particularly vulnerable to the threat of AMR. In response, the government launched the National Action Plan on Antimicrobial Resistance (NAP-AMR) in 2017, aligning with the WHO’s Global Action Plan.

The core of India’s strategy is the ‘One Health’ approach, which recognizes that the health of people is closely connected to the health of animals and our shared environment.

Recent Developments (2023-2025):

• Strengthened Surveillance (2024): The Indian Council of Medical Research (ICMR) has expanded its AMR surveillance network to include more labs and cover a wider range of pathogens. The data from this network is now being used to formulate state-specific action plans, with several states like Kerala and Madhya Pradesh having already launched their own SAP-AMR.
• FSSAI Regulation on Animal Feed (2023): The Food Safety and Standards Authority of India (FSSAI) issued an order prohibiting the use of Colistin, a last-resort antibiotic, as a growth promoter in animal feed, a significant step in curbing agricultural AMR.
• AMR Action Funnel (2024): To accelerate progress, the WHO has introduced the “AMR Action Funnel,” a tool designed to help countries like India identify and prioritize interventions based on their specific national context and available resources, a strategy being actively discussed for integration into the next phase of NAP-AMR.

Analogy: Think of antibiotics as a team of elite firefighters. When we overuse them for small “fires” (minor infections) or don’t use them correctly, the “arsonists” (bacteria) learn their tactics. Eventually, when a massive “inferno” (a serious infection) breaks out, the firefighters find their methods are useless, and the fire rages out of control. That’s AMR.

Critical Policy Appraisal

Analytical Lens: UPSC Focus (Mains & Prelims)

Conceptual Basis: The foundational policy document for this topic is India’s National Action Plan on Antimicrobial Resistance (NAP-AMR, 2017-2021) and its subsequent iterations. It operates under the global framework set by the WHO Global Action Plan on AMR.

UPSC Integration: Connecting the Dots

• GS Paper 2 (Health, Governance): AMR is a core public health issue. Evaluating the effectiveness of NAP-AMR falls under governance and policy implementation. It also involves international cooperation with bodies like the WHO, FAO, and World Organisation for Animal Health.
• GS Paper 3 (Science & Tech, Economy, Environment): The topic links directly to S&T through biotechnology and the need for new drug R&D. Economically, AMR imposes a huge burden through increased healthcare costs and productivity loss. Environmentally, the disposal of pharmaceutical waste is a key driver.
• GS Paper 4 (Ethics): The issue involves ethical dilemmas for doctors (prescription practices), patients (compliance), and pharmaceutical companies (profit motives vs. public health).

Future Impact & Policy Relevance: AMR is not just a health crisis; it is a national security and development crisis. If unchecked, it will unravel decades of medical progress, making routine surgeries, cancer chemotherapy, and organ transplants life-threatening. It threatens food security through its impact on livestock and agriculture. For India, tackling AMR is non-negotiable for achieving its Sustainable Development Goals (SDGs), particularly SDG 3 (Good Health and Well-being). Future policy must focus on a mission-mode implementation of the ‘One Health’ approach, with stringent regulation, massive public awareness campaigns, and incentivizing new antibiotic research.

Prelims Practice Question (MCQ):

Which of the following statements most accurately describes the ‘One Health’ approach, often cited in the context of tackling Antimicrobial Resistance? a) A strategy focused exclusively on developing new antibiotics for human use. b) A collaborative, multisectoral, and transdisciplinary approach that recognizes the interconnection between people, animals, plants, and their shared environment. c) A policy to provide universal health coverage to all citizens of a country. d) A framework for standardizing hospital infection control protocols globally.

Answer and Explanation: Correct Answer: (b). The ‘One Health’ concept is a holistic approach that acknowledges the intricate links between human health, animal health, and the environment. It is the cornerstone of modern strategies against zoonotic diseases and AMR, as pathogens and resistance can cross between these domains.

Mains Sample Question:

“Antimicrobial Resistance (AMR) is a ‘silent pandemic’ that poses a significant threat to India’s public health and economic stability. Critically analyze the objectives and implementation of India’s National Action Plan on AMR, suggesting multi-pronged measures to strengthen the ‘One Health’ framework for a more effective response. (15 Marks, 250 Words)“

Mind Map Outline (Revision Structure)

• Communicable Diseases & Antimicrobial Resistance
  • Defining Health & Disease
    • WHO Definition of Health
    • Communicable vs. Non-Communicable Diseases
  • Transmission of Communicable Diseases
    • Direct Contact
    • Indirect Contact
    • Vector-Borne
    • Airborne
  • Antimicrobial Resistance (AMR): The Core Issue
    • Definition: Microbes evolving to resist medicines.
    • Key Drivers of AMR (Mnemonic: MASTER)
      • Misuse in Medicine
      • Agricultural Use
      • Sanitation Deficits
      • Therapeutic Non-compliance
      • Environmental Contamination
      • Regulatory Gaps
    • India’s Response to AMR
      • National Action Plan on AMR (NAP-AMR)
        • Core Principle: ‘One Health’ Approach
        • Strategic Objectives: Awareness, Surveillance, Infection Control, Optimized Use, R&D, International Collaboration.
      • Recent Initiatives (2023-2025)
        • Expansion of ICMR Surveillance Network (2024)
        • FSSAI Ban on Colistin in Animal Feed (2023)
        • Adoption of WHO’s AMR Action Funnel (2024)
    • Critical Policy Appraisal
      • Challenges: OTC sales, low awareness, infrastructure gaps.
      • Way Forward: Stricter enforcement, public campaigns, integrating with national missions (Swachh Bharat).
  • UPSC Analytical Focus
    • Legal/Policy Basis: NAP-AMR, WHO Global Action Plan
    • Inter-Topic Linkages: GS-2 (Health, Governance), GS-3 (S&T, Economy), GS-4 (Ethics)
    • Future Implications: Threat to SDGs, National Security, and Economic Development.